Tuberculin skin test – Outdated or still useful for Latent TB infection screening?

Gina Gualano, Paola Mencarini, Francesco Nicola Lauria, Fabrizio Palmieri, Sayoki Mfinanga, Peter Mwaba, Jeremiah Chakaya, Alimuddin Zumla, Giuseppe Ippolito

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To make an informed viewpoint on the usefulness of Tuberculin Skin test (TST) compared to Interferon Gamma Release Assays (IGRAs) for diagnosis of Latent TB Infection (LTBI) in different geographical settings. Methods: We reviewed the current literature on TST compared to IGRA, including national implementation of WHO LTBI recommendations and retrospective data over the past 7 years at the National Institute for Infectious Diseases “L. Spallanzani” as indirect indicator of usage of both tests under actual programmatic conditions. Results: Current national guidelines vary considerably, reflecting the uncertainty and rapidly evolving evidence about the potential use of these tests. Data from Institute “L. Spallanzani” showed IGRA concordance in TST positive subjects only in 54.74% of subjects, while there was strong concordance between two tests in TST negative subjects (93.78%). Conclusion: Neither IGRAs nor TST can distinguish active TB from LTBI. TST will continue to be clinically useful in low and high TB endemic areas until more accurate and predictive tests will become available. Clinical judgment remains fundamental in choosing between IGRA/TST tests and interpreting their results.

Original languageEnglish
Pages (from-to)S20-S22
Number of pages3
JournalInternational Journal of Infectious Diseases
Volume80
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

Tuberculin Test
Interferon-gamma Release Tests
Skin Tests
Infection
Uncertainty
Communicable Diseases
Guidelines

Keywords

  • IGRA
  • Interferon-γ release assays
  • Latent TB
  • LTBI
  • Quantiferon
  • TB
  • TST
  • Tuberculin skin test
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Tuberculin skin test – Outdated or still useful for Latent TB infection screening? / Gualano, Gina; Mencarini, Paola; Lauria, Francesco Nicola; Palmieri, Fabrizio; Mfinanga, Sayoki; Mwaba, Peter; Chakaya, Jeremiah; Zumla, Alimuddin; Ippolito, Giuseppe.

In: International Journal of Infectious Diseases, Vol. 80, 01.03.2019, p. S20-S22.

Research output: Contribution to journalArticle

Gualano, Gina ; Mencarini, Paola ; Lauria, Francesco Nicola ; Palmieri, Fabrizio ; Mfinanga, Sayoki ; Mwaba, Peter ; Chakaya, Jeremiah ; Zumla, Alimuddin ; Ippolito, Giuseppe. / Tuberculin skin test – Outdated or still useful for Latent TB infection screening?. In: International Journal of Infectious Diseases. 2019 ; Vol. 80. pp. S20-S22.
@article{e32d32e1724f48fdbb95b3accb4dca7f,
title = "Tuberculin skin test – Outdated or still useful for Latent TB infection screening?",
abstract = "Objective: To make an informed viewpoint on the usefulness of Tuberculin Skin test (TST) compared to Interferon Gamma Release Assays (IGRAs) for diagnosis of Latent TB Infection (LTBI) in different geographical settings. Methods: We reviewed the current literature on TST compared to IGRA, including national implementation of WHO LTBI recommendations and retrospective data over the past 7 years at the National Institute for Infectious Diseases “L. Spallanzani” as indirect indicator of usage of both tests under actual programmatic conditions. Results: Current national guidelines vary considerably, reflecting the uncertainty and rapidly evolving evidence about the potential use of these tests. Data from Institute “L. Spallanzani” showed IGRA concordance in TST positive subjects only in 54.74{\%} of subjects, while there was strong concordance between two tests in TST negative subjects (93.78{\%}). Conclusion: Neither IGRAs nor TST can distinguish active TB from LTBI. TST will continue to be clinically useful in low and high TB endemic areas until more accurate and predictive tests will become available. Clinical judgment remains fundamental in choosing between IGRA/TST tests and interpreting their results.",
keywords = "IGRA, Interferon-γ release assays, Latent TB, LTBI, Quantiferon, TB, TST, Tuberculin skin test, Tuberculosis",
author = "Gina Gualano and Paola Mencarini and Lauria, {Francesco Nicola} and Fabrizio Palmieri and Sayoki Mfinanga and Peter Mwaba and Jeremiah Chakaya and Alimuddin Zumla and Giuseppe Ippolito",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.ijid.2019.01.048",
language = "English",
volume = "80",
pages = "S20--S22",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Tuberculin skin test – Outdated or still useful for Latent TB infection screening?

AU - Gualano, Gina

AU - Mencarini, Paola

AU - Lauria, Francesco Nicola

AU - Palmieri, Fabrizio

AU - Mfinanga, Sayoki

AU - Mwaba, Peter

AU - Chakaya, Jeremiah

AU - Zumla, Alimuddin

AU - Ippolito, Giuseppe

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Objective: To make an informed viewpoint on the usefulness of Tuberculin Skin test (TST) compared to Interferon Gamma Release Assays (IGRAs) for diagnosis of Latent TB Infection (LTBI) in different geographical settings. Methods: We reviewed the current literature on TST compared to IGRA, including national implementation of WHO LTBI recommendations and retrospective data over the past 7 years at the National Institute for Infectious Diseases “L. Spallanzani” as indirect indicator of usage of both tests under actual programmatic conditions. Results: Current national guidelines vary considerably, reflecting the uncertainty and rapidly evolving evidence about the potential use of these tests. Data from Institute “L. Spallanzani” showed IGRA concordance in TST positive subjects only in 54.74% of subjects, while there was strong concordance between two tests in TST negative subjects (93.78%). Conclusion: Neither IGRAs nor TST can distinguish active TB from LTBI. TST will continue to be clinically useful in low and high TB endemic areas until more accurate and predictive tests will become available. Clinical judgment remains fundamental in choosing between IGRA/TST tests and interpreting their results.

AB - Objective: To make an informed viewpoint on the usefulness of Tuberculin Skin test (TST) compared to Interferon Gamma Release Assays (IGRAs) for diagnosis of Latent TB Infection (LTBI) in different geographical settings. Methods: We reviewed the current literature on TST compared to IGRA, including national implementation of WHO LTBI recommendations and retrospective data over the past 7 years at the National Institute for Infectious Diseases “L. Spallanzani” as indirect indicator of usage of both tests under actual programmatic conditions. Results: Current national guidelines vary considerably, reflecting the uncertainty and rapidly evolving evidence about the potential use of these tests. Data from Institute “L. Spallanzani” showed IGRA concordance in TST positive subjects only in 54.74% of subjects, while there was strong concordance between two tests in TST negative subjects (93.78%). Conclusion: Neither IGRAs nor TST can distinguish active TB from LTBI. TST will continue to be clinically useful in low and high TB endemic areas until more accurate and predictive tests will become available. Clinical judgment remains fundamental in choosing between IGRA/TST tests and interpreting their results.

KW - IGRA

KW - Interferon-γ release assays

KW - Latent TB

KW - LTBI

KW - Quantiferon

KW - TB

KW - TST

KW - Tuberculin skin test

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85061941061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061941061&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2019.01.048

DO - 10.1016/j.ijid.2019.01.048

M3 - Article

C2 - 30738186

AN - SCOPUS:85061941061

VL - 80

SP - S20-S22

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -